Free Trial

Evoke (LON:EVOK) Stock Price Down 18.7% - Here's What Happened

Evoke logo with Consumer Cyclical background
Remove Ads

Evoke plc (LON:EVOK - Get Free Report) dropped 18.7% during trading on Wednesday . The stock traded as low as GBX 56 ($0.72) and last traded at GBX 58.05 ($0.75). Approximately 55,595,465 shares were traded during trading, an increase of 1,853% from the average daily volume of 2,847,325 shares. The stock had previously closed at GBX 71.40 ($0.92).

Analyst Upgrades and Downgrades

EVOK has been the topic of a number of analyst reports. Berenberg Bank dropped their price target on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a "buy" rating on the stock in a research note on Wednesday, December 4th. Jefferies Financial Group reissued a "buy" rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a research report on Monday, December 16th.

Read Our Latest Stock Analysis on EVOK

Evoke Price Performance

The company has a market cap of £224.78 million, a PE ratio of -1.26 and a beta of 0.84. The stock has a fifty day moving average price of GBX 68.88 and a 200-day moving average price of GBX 63.49.

Evoke (LON:EVOK - Get Free Report) last announced its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, equities analysts anticipate that Evoke plc will post 12.7648305 earnings per share for the current year.

Insider Transactions at Evoke

In related news, insider Andrea Gisle Joosen purchased 14,572 shares of the stock in a transaction dated Tuesday, January 28th. The shares were acquired at an average cost of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,189.04). 27.00% of the stock is owned by insiders.

About Evoke

(Get Free Report)

Featured Stories

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads